Blueberries Medical Corp. (OTCQB: BBRRF) (CSE:BBM) (FRA:1OA) released its financial results for the quarter ended on June 30, 2022, revealing total revenue of CA$39,826, an increase of CA$25,041 (or 169%) compared to Q2 2021.
Q2 2022 Financial Highlights
The gross profit, excluding the direct cost of production, in the extraction services is approximately 11%.
Gross profit was a loss of CA$75,475 compared to a loss of CA$88,021 in Q2 2021.
Net loss was CA$511,717 compared to net loss of CA$269,067 in Q2 2021
The company has pivoted its core business from cultivation to the extraction services, and identified a niche in export market of isolated products to the Latin America countries. To date, the company has been successful in exporting isolated products to Argentina. “Accordingly, in aligning with the company’s strategy, the company has begun to expand its commercial revenues, adding more final products and services to others cannabis companies in Colombia and …